Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mouse models for generating P53 gene mutation spectra.

Boris Zielinski1, Zhipei Liu, Monica Hollstein

  • 1Department of Genetic Alterations in Carcinogenesis, German Cancer Research Center, Dept C0700, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany.

Toxicology Letters
|August 23, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The functions of FXYD family members in human health and disease.

Genes & diseases·2026
Same author

Rewiring tumor immunity via zinc finger proteins: a new frontier in cancer immunotherapy.

Journal of translational medicine·2025
Same author

Advances in chemogenetics: a review of DREADDs and its application in psychiatric disorders.

Molecular psychiatry·2025
Same author

The role of GPI-anchored LY6/uPAR family proteins in connecting membrane microdomains with immune regulation and diseases.

Critical reviews in oncology/hematology·2025
Same author

DIRAS1 Drives Oxaliplatin Resistance in Colorectal Cancer via PHB1-Mediated Mitochondrial Homeostasis.

Biology·2025
Same author

ApoE Inhibits the Progression of Glioma by Activating Immune Function.

Journal of cellular and molecular medicine·2025
Same journal

LEF1 regulated CTHRC1 promotes silica-induced pulmonary fibrosis through CD44-dependent signaling.

Toxicology letters·2026
Same journal

hERG channel blockade and additive interactions of magnolol and honokiol from Magnolia species.

Toxicology letters·2026
Same journal

Evaluation of dose-dependent hematotoxic effects of celastrol on human blood cells in vitro.

Toxicology letters·2026
Same journal

Environmental pharmaceutical and antibiotic mixtures: An exposomics-guided framework for mechanistic toxicology.

Toxicology letters·2026
Same journal

Size- and morphology-dependent cytotoxicity of metal-organic frameworks: Deciphering the structure-toxicity relationship.

Toxicology letters·2026
Same journal

Steroidogenesis suppression in H295R cells by 1,3-disubstituted ureas: A potential off-target effect of some sEH inhibitors.

Toxicology letters·2026
See all related articles

Analyzing p53 tumor suppressor gene mutations in mice reveals insights into cancer development. This research uses a new mouse model to explore factors contributing to neoplastic disease, advancing our understanding of human cancer origins.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • The p53 tumor suppressor gene is frequently mutated in human cancers.
  • Previous studies of experimentally induced p53 mutations in mice have offered limited insights into human cancer mutagenic mechanisms.
  • A gap exists in understanding the endogenous and environmental factors driving human neoplastic disease.

Purpose of the Study:

  • To investigate the utility of p53 mutation spectra analysis in understanding cancer development.
  • To explore the contribution of endogenous and environmental factors to neoplastic disease using a novel mouse model.

Main Methods:

  • Utilizing gene-targeting technology to develop a new mouse model.
  • Analyzing mutation spectra of the p53 gene in experimentally induced tumors.

Related Experiment Videos

  • Investigating the influence of carcinogens and genetic modifications on p53 mutation patterns.

    • Main Results:

    • The p53 gene is amenable to mutation spectra analysis due to high mutation frequencies and diverse mutation types observed in human tumors.
    • Experimentally induced p53 mutations in mice have been documented but have not significantly advanced the understanding of human cancer origins.
    • The newly developed mouse model allows for experimental exploration of factors contributing to neoplastic disease.

    Conclusions:

    • The p53 tumor suppressor gene is a valuable target for mutation spectra analysis in cancer research.
    • New mouse models employing gene-targeting technology are crucial for dissecting the complex interplay of factors in human cancer development.
    • Further research with this model is expected to elucidate mutagenic mechanisms and the origins of mutations in human cancers.